These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1856924)

  • 1. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder.
    Klän R; Loy V; Huland H
    J Urol; 1991 Aug; 146(2):316-8. PubMed ID: 1856924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of a second transurethral resection for T1 bladder cancer.
    Schwaibold HE; Sivalingam S; May F; Hartung R
    BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
    Süer E; Özcan C; Baltacı S; Gülpınar Ö; Burgu B; Haliloğlu A; Bedük Y
    Urol Int; 2013; 91(2):182-6. PubMed ID: 23751593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Re-Resection in T1 Bladder Cancer: Identifying Patients Who Do Not Receive Guideline-Concordant Care at the Population Level.
    Wettstein MS; Baxter NN; Sutradhar R; Mamdani M; Song P; Qadri SR; Bhalla G; Li K; Liu N; van der Kwast T; Hermanns T; Kulkarni GS
    J Urol; 2022 Feb; 207(2):314-323. PubMed ID: 34547923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma].
    Vögeli TA; Grimm MO; Simon X; Ackermann R
    Urologe A; 2002 Sep; 41(5):470-4. PubMed ID: 12426865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
    Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
    Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.
    Grimm MO; Steinhoff C; Simon X; Spiegelhalder P; Ackermann R; Vogeli TA
    J Urol; 2003 Aug; 170(2 Pt 1):433-7. PubMed ID: 12853793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of a second transurethral resection in evaluating patients with bladder tumors.
    Herr HW
    J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer.
    Sivalingam S; Probert JL; Schwaibold H
    BJU Int; 2005 Oct; 96(6):759-62. PubMed ID: 16153194
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of a second transurethral resection on the staging of T1 bladder cancer.
    Dalbagni G; Herr HW; Reuter VE
    Urology; 2002 Nov; 60(5):822-4; discussion 824-5. PubMed ID: 12429307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
    Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
    J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second-look TUR in T1 transitional cell carcinoma: why?
    Jakse G; Algaba F; Malmström PU; Oosterlinck W
    Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
    Richards KA; Smith ND; Steinberg GD
    J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists.
    Zurkirchen MA; Sulser T; Gaspert A; Hauri D
    Urol Int; 2004; 72(2):99-102. PubMed ID: 14963348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
    Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
    Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Pro.
    Herr HW
    J Urol; 2011 Sep; 186(3):787-8. PubMed ID: 21788040
    [No Abstract]   [Full Text] [Related]  

  • 20. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
    Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
    J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.